Rick Wise
Stock Analyst at Stifel Nicolaus
(1.06)
# 3,863
Out of 4,993 analysts
802
Total ratings
48%
Success rate
-0.6%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOLV Solventum | Reiterated: Buy | $100 | $88.75 | +12.68% | 13 | Sep 18, 2026 | |
| ATRC AtriCure | Reiterated: Buy | $50 → $65 | $58.83 | +10.49% | 36 | Sep 17, 2026 | |
| KMTS Kestra Medical Technologies | Reiterated: Buy | $30 | $26.09 | +14.99% | 9 | Sep 15, 2026 | |
| MDT Medtronic | Reiterated: Hold | $80 → $95 | $90.77 | +4.66% | 51 | Sep 2, 2026 | |
| HTFL HeartFlow | Reiterated: Buy | $40 → $45 | $50.17 | -10.30% | 7 | Aug 14, 2026 | |
| BDX Becton, Dickinson and Company | Reiterated: Buy | $195 | $183.00 | +6.56% | 33 | Aug 11, 2026 | |
| TMCI Treace Medical Concepts | Reiterated: Hold | $3 → $4.5 | $4.59 | -1.96% | 25 | Aug 11, 2026 | |
| AORT Artivion | Reiterated: Buy | $45 | $24.13 | +86.49% | 21 | Aug 7, 2026 | |
| OM Outset Medical | Reiterated: Buy | $6 | $3.29 | +82.37% | 31 | Aug 7, 2026 | |
| TSX: PRN Profound Medical Corp. | Reiterated: Buy | $13.99 | $8.25 | +69.52% | 11 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 → $45 | $34.43 | +30.70% | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $105 → $110 | $93.98 | +17.05% | 48 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $24 | $22.76 | +5.45% | 33 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $85 | $78.49 | +8.29% | 37 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $80.98 | +48.18% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 → $28 | $23.68 | +18.24% | 37 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $66.27 | +20.72% | 18 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $2.06 | +21.36% | 22 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $60 | $44.92 | +33.57% | 67 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $88.78 | +23.90% | 51 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $670 → $550 | $402.09 | +36.79% | 49 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $250 → $260 | $269.19 | -3.41% | 31 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $440 → $360 | $275.09 | +30.87% | 34 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $145 → $120 | $103.69 | +15.73% | 44 | Apr 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 | $46.17 | n/a | 32 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.0001 | n/a | 8 | Jun 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $25 → $30 | $1.95 | n/a | 13 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $34 | $17.50 | n/a | 9 | Aug 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $521.50 | n/a | 2 | Nov 8, 2012 |
Solventum
Sep 18, 2026
Reiterated: Buy
Price Target: $100
Current: $88.75
Upside: +12.68%
AtriCure
Sep 17, 2026
Reiterated: Buy
Price Target: $50 → $65
Current: $58.83
Upside: +10.49%
Kestra Medical Technologies
Sep 15, 2026
Reiterated: Buy
Price Target: $30
Current: $26.09
Upside: +14.99%
Medtronic
Sep 2, 2026
Reiterated: Hold
Price Target: $80 → $95
Current: $90.77
Upside: +4.66%
HeartFlow
Aug 14, 2026
Reiterated: Buy
Price Target: $40 → $45
Current: $50.17
Upside: -10.30%
Becton, Dickinson and Company
Aug 11, 2026
Reiterated: Buy
Price Target: $195
Current: $183.00
Upside: +6.56%
Treace Medical Concepts
Aug 11, 2026
Reiterated: Hold
Price Target: $3 → $4.5
Current: $4.59
Upside: -1.96%
Artivion
Aug 7, 2026
Reiterated: Buy
Price Target: $45
Current: $24.13
Upside: +86.49%
Outset Medical
Aug 7, 2026
Reiterated: Buy
Price Target: $6
Current: $3.29
Upside: +82.37%
Profound Medical Corp.
Aug 7, 2026
Reiterated: Buy
Price Target: $13.99
Current: $8.25
Upside: +69.52%
Aug 6, 2026
Rated: Buy
Price Target: $50 → $45
Current: $34.43
Upside: +30.70%
Aug 6, 2026
Rated: Buy
Price Target: $105 → $110
Current: $93.98
Upside: +17.05%
Aug 5, 2026
Reiterated: Buy
Price Target: $22 → $24
Current: $22.76
Upside: +5.45%
Aug 5, 2026
Reiterated: Buy
Price Target: $80 → $85
Current: $78.49
Upside: +8.29%
Aug 5, 2026
Reiterated: Buy
Price Target: $120
Current: $80.98
Upside: +48.18%
Jul 31, 2026
Reiterated: Hold
Price Target: $19 → $28
Current: $23.68
Upside: +18.24%
Jul 30, 2026
Reiterated: Buy
Price Target: $80
Current: $66.27
Upside: +20.72%
Jul 30, 2026
Reiterated: Buy
Price Target: $2.5
Current: $2.06
Upside: +21.36%
Jul 29, 2026
Reiterated: Buy
Price Target: $65 → $60
Current: $44.92
Upside: +33.57%
Jul 24, 2026
Reiterated: Buy
Price Target: $110
Current: $88.78
Upside: +23.90%
Jul 17, 2026
Rated: Buy
Price Target: $670 → $550
Current: $402.09
Upside: +36.79%
Jul 15, 2026
Reiterated: Hold
Price Target: $250 → $260
Current: $269.19
Upside: -3.41%
May 1, 2026
Reiterated: Buy
Price Target: $440 → $360
Current: $275.09
Upside: +30.87%
Apr 17, 2026
Rated: Buy
Price Target: $145 → $120
Current: $103.69
Upside: +15.73%
May 1, 2025
Reiterated: Hold
Price Target: $55
Current: $46.17
Upside: n/a
Jun 3, 2023
Reiterated: Hold
Price Target: $1
Current: $0.0001
Upside: n/a
Feb 25, 2019
Upgraded: Buy
Price Target: $25 → $30
Current: $1.95
Upside: n/a
Aug 22, 2018
Reiterated: Hold
Price Target: $25 → $34
Current: $17.50
Upside: n/a
Nov 8, 2012
Rated: Hold
Price Target: n/a
Current: $521.50
Upside: n/a